Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials

Overview of attention for article published in Frontiers in Pharmacology, December 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

So far, Altmetric has seen 1 X post from an account with 5,782 followers.

New Research: Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials https://t.co/GBeMbPITDS #pharmacology

15 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.